Potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with P-MAPA and systemic administration of cisplatin and doxorubicin-Reference-Cited by-同舟云学术

Potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with P-MAPA and systemic administration of cisplatin and doxorubicin

Published:2016-10 Issue:5 Volume:42 Page:942-954
ISSN:1677-5538
Container-title:International braz j urol
language:
Short-container-title:Int. braz j urol.

Author:

Dias Queila Cristina¹,Nunes Iseu da Silva²,Garcia Patrick Vianna¹,Fávaro Wagner José³

Affiliation:

1. Universidade de Campinas, Brasil

2. FarmaBrasilis R & D, Brasil

3. Universidade de Campinas, Brasil; FarmaBrasilis R & D, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

Urology

Link

http://www.scielo.br/pdf/ibju/v42n5/1677-5538-ibju-42-05-0942.pdf

Reference30 articles.

1. Bladder Cancer Immunotherapy: BCG and Beyond;Askeland EJ;Adv Urol,2012

2. BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study;Herr HW;Urol Oncol,2015

3. NCCN Clinical Practice Guidelines in Oncology,2014

4. Non Muscle Invasive Bladder Cancer Treatment;Cavaliere C;WCRJ,2014

5. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin;Subedi RK;Eur J Pharm Sci,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of P-MAPA Immunotherapy Associated with Gemcitabine on Chemically-Induced Pancreatic Cancer in Animal Model: New Therapeutic Perspectives;Biointerface Research in Applied Chemistry;2021-11-25

2. Associating Graphene Oxide Derivatives to Treat Non-Muscle Invasive Bladder Cancer (NMIBC);Biointerface Research in Applied Chemistry;2021-04-19

3. Research on new drugs in the therapy of bladder cancer (BC);Postępy Higieny i Medycyny Doświadczalnej;2018-05-17

4. Advances and Perspectives in Urinary Bladder Cancer Nanotherapy;EMJ Urology;2018-05-08

5. P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling;Journal of Ovarian Research;2018-01-17